NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,992 Cr | ₹2,184 Cr | ₹2,169 Cr | ₹2,388 Cr | ₹2,376 Cr |
What is the latest Total Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,992 Cr |
| Mar2024 | ₹2,184 Cr |
| Mar2023 | ₹2,169 Cr |
| Mar2022 | ₹2,388 Cr |
| Mar2021 | ₹2,376 Cr |
How is Total Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,992 Cr | -8.77 | |
| Mar2024 | ₹2,184 Cr | 0.69 | |
| Mar2023 | ₹2,169 Cr | -9.19 | |
| Mar2022 | ₹2,388 Cr | 0.51 | |
| Mar2021 | ₹2,376 Cr | - | |
Compare Total Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹313.6 Cr | -11.9% | -3.1% | -62.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,810.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -11.9% |
-3.1% |
-62.1% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses